Nice work. I would say that settles it in my mind then. Thanks for clearing it up. So ORXE shares are trading at 50% of cash and near-cash reserves, then?
One other thing -- seems to me that a hadge fund strategy or somebody out there flipped a switch to short every EPS negative biotech stock under a dollar a share last week. From the git-go on Monday, there was a pretty aggressive bid assault this past week all over the place... several stocks I watch were under pressure.... Look for a weak week ahead and recovery after that... if "they" are able to cover... or... even better... with ORXE, the trade is so thin, maybe nobody will panic sell to these bastards and make them cover a lot higher...........
News 
Market Data 
Discover 
AI
